Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Elana Bernstein, MD, MSc
Columbia University
New York, NY, United States
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing)
Zsuzsanna McMahan, MD, MHS
Johns Hopkins Rheumatology
Lutherville, MD, United States
Disclosure(s): Cumberland: I help with skin biopsies for a clinical trial at Hopkins (Ongoing); Horizon: I was going to be a sub-I but did not do it as I was interested in helping with the ACR ILD Guideline Development (Terminated); Kadmon: I help with skin biopsies for a clinical trial at Hopkins (Ongoing); Mitsubishi: I help with skin biopsies for a clinical trial at Hopkins (Ongoing)
Systemic sclerosis (SSc) is a systemic autoimmune rheumatic disease that affects multiple organ systems. Cardiac involvement is an important cause of mortality in patients with SSc, and esophageal disease results in high morbidity in this population. This session will review the presentation, evaluation, and treatment of cardiac disease and esophageal disease in SSc.
Speaker: Laura Ross – The University of Melbourne at St. Vincent's Hospital
Speaker: Michael Hughes, PhD, MBBS, BSc, MSc, MRCP – Tameside and Glossop Integrated NHS Foundation Trust & The University of Manchester
Speaker: Rishi Naik, MD, MSc – Vanderbilt University Medical Center
